首页> 外文期刊>Japanese Journal of Pharmacology >A nuclear factor-kappaB inhibitor BAY 11-7082 suppresses endothelin-1 production in cultured vascular endothelial cells.
【24h】

A nuclear factor-kappaB inhibitor BAY 11-7082 suppresses endothelin-1 production in cultured vascular endothelial cells.

机译:核因子-κB抑制剂BAY 11-7082抑制培养的血管内皮细胞中内皮素1的产生。

获取原文
获取原文并翻译 | 示例
           

摘要

BAY 11-7082, an inhibitor of nuclear factor-kappaB (NF-kappaB), which prevents a step of the phosphorylation of inhibitory protein IkappaB bound to NF-kappaB, suppressed basal and tumor necrosis factor (TNF)-alpha-induced prepro endothelin (ET)-1 mRNA expression and NF-kappaB activation in cultured vascular endothelial cells. BAY 11-7082 significantly decreased basal and TNF-alpha-induced ET-1 release from endothelial cells. These results indicate that the inhibition of NF-kappaB activation contributes to the suppressive effect of BAY 11-7082 on ET-1 gene expression and ET-1 release, thereby suggesting that NF-kappaB plays an important role in the regulation of ET-1 production.
机译:BAY 11-7082,一种核因子-kappaB(NF-kappaB)抑制剂,可阻止与NF-kappaB结合的抑制性蛋白IkappaB磷酸化,抑制了基础和肿瘤坏死因子(TNF)-α诱导的前原内皮素培养的血管内皮细胞中的(ET)-1 mRNA表达和NF-κB活化。 BAY 11-7082显着降低了基础细胞和TNF-α诱导的ET-1从内皮细胞的释放。这些结果表明,NF-κB活化的抑制有助于BAY 11-7082对ET-1基因表达和ET-1释放的抑制作用,从而表明NF-κB在ET-1的调节中起重要作用。生产。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号